Bortezomib and Paclitaxel in Treating Patients With Locally Advanced or Metastatic Solid Tumors

NCT00030368 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

45

Enrollment

NIH

Sponsor class

Conditions

Unspecified Adult Solid Tumor, Protocol Specific

Interventions

DRUG: bortezomib
DRUG: paclitaxel
OTHER: laboratory biomarker analysis

Sponsor

National Cancer Institute (NCI)